Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia - Concepedia

Concepedia

Publication | Open Access

Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia

DOI Full Paper Access

101

Citations

42

References

2017

Year

Meenu Kesarwani, Zachary Kincaid, A. H. Gomaa, Erika Huber, Sara Rohrabaugh, Zain Siddiqui, Muhammad F. Bouso, Tahir Latif, Ming Xu, Kakajan Komurov,

Nature Medicine

Intrinsic ResistanceHematological MalignancyBcr-abl-induced LeukemiaMedicineMixed-phenotype Acute LeukemiaReceptor Tyrosine KinaseImmune Checkpoint InhibitorPharmacologyCell BiologyCell SignalingTumor BiologyTyrosine-kinase Inhibitor TherapyDrug Resistance

References

	Year	Citations

Page 1

Page 1